Skip to content

Member

Elena NEVADO DEL CAMPO

EPP · Spain

Group
EPP PPE
Country
Spain
Roll-call participation
89.0 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
93.6 %ⓘ of 5 276 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
PP Partido Popular
In office
Since 16 Jul 2024
Against clear line
212 of 5 019 votesⓘ
Committees
FEMM (substitute), PETI, REGI, SANT
Member id
257039
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.0 %

5 276 of 5 928 roll calls while in office

EPP median: 89.9 % (−0.9 pts)

Chamber median: 90.2 %

With majority line ⓘ

93.6 %

4 937 of 5 276 votes where their group had a line

EPP median: 93.6 % (±0.0 pts)

Against clear line ⓘ

4.2 %

212 of 5 019 votes where their group had a clear line

136 opposite (for ↔ against), 75 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

2.6 %

136 of 5 276 votes cast

Participation 89.0 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Elena NEVADO DEL CAMPO89.0 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 93.6 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Elena NEVADO DEL CAMPO93.6 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: Against ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: Abstained ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: Against Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: Abstained Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: Abstained Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: Abstained ≠ groupMajority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: Against Majority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 24 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202420
18 Sept 202422
19 Sept 2024920
7 Oct 202420
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202420
22 Oct 2024108
23 Oct 2024129126
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202420
26 Nov 20241817
27 Nov 20241111
28 Nov 20245756
17 Dec 20241312
18 Dec 20243333
19 Dec 20244545
20 Jan 202520
21 Jan 202511
22 Jan 202522
23 Jan 20254540
10 Feb 202511
11 Feb 20253232
12 Feb 2025109
13 Feb 20253028
10 Mar 202520
11 Mar 202598
12 Mar 2025228228
13 Mar 20252424
31 Mar 202530
1 Apr 20253535
2 Apr 2025251244
3 Apr 20256262
5 May 202550
6 May 20251010
7 May 2025220217
8 May 202510387
21 May 202522
22 May 20255353
16 Jun 202520
17 Jun 20254141
18 Jun 20259190
19 Jun 20258787
7 Jul 202510
8 Jul 2025550
9 Jul 20251340
10 Jul 2025360
8 Sept 202510
9 Sept 2025101101
10 Sept 20253434
11 Sept 20256969
6 Oct 202520
7 Oct 202555
8 Oct 20255555
9 Oct 20256563
20 Oct 202530
21 Oct 20251313
22 Oct 2025186185
23 Oct 20255555
13 Nov 2025267264
24 Nov 202530
25 Nov 20257575
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202540
16 Dec 20256661
17 Dec 20254343
18 Dec 20254241
20 Jan 20266767
21 Jan 2026112111
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141136
24 Feb 20264343
9 Mar 202611
10 Mar 2026197194
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225222
29 Apr 2026296293
30 Apr 20266867
18 May 202640
19 May 202633
20 May 20269696
21 May 20269895
15 Jun 202620
16 Jun 20264040
17 Jun 2026127127
18 Jun 20267777
6 Jul 202620
7 Jul 20267272
8 Jul 20261440
9 Jul 2026670
14 Sept 202611
15 Sept 2026155154
16 Sept 20268077
17 Sept 2026124123

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Alma EZCURRA ALMANSA EPPSpain99 % of 1 579 shared89 %
Maravillas ABADÍA JOVER EPPSpain98 % of 4 976 shared89 %
Fernando NAVARRETE ROJAS EPPSpain98 % of 5 085 shared89 %
Antonio LÓPEZ-ISTÚRIZ WHITE EPPSpain98 % of 4 606 shared89 %
Carmen CRESPO DÍAZ EPPSpain98 % of 4 506 shared89 %
Gabriel MATO EPPSpain98 % of 4 687 shared89 %
Borja GIMÉNEZ LARRAZ EPPSpain98 % of 5 142 shared89 %
Susana SOLÍS PÉREZ EPPSpain98 % of 4 451 shared89 %
Javier ZARZALEJOS EPPSpain97 % of 5 028 shared89 %
Pablo ARIAS ECHEVERRÍA EPPSpain97 % of 4 854 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia84 % of 4 716 shared82 %
Andreas GLÜCK RenewGermany83 % of 3 494 shared82 %
Dan BARNA RenewRomania83 % of 4 584 shared82 %
Bart GROOTHUIS RenewNetherlands83 % of 3 886 shared82 %
Hilde VAUTMANS RenewBelgium83 % of 5 102 shared82 %
Katri KULMUNI RenewFinland83 % of 4 095 shared82 %
Jan-Christoph OETJEN RenewGermany82 % of 5 102 shared82 %
Jeannette BALJEU RenewNetherlands82 % of 4 583 shared82 %
Eugen TOMAC RenewRomania82 % of 3 855 shared82 %
Olivier CHASTEL RenewBelgium82 % of 4 819 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute19 Jul 2024now
Committee on PetitionsPETI CommitteeMember8 Sept 2025now
Committee on Regional DevelopmentREGI CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with the countries of Central America, including the EU-Central America Association Parliamentary CommitteeDCAM DelegationVice-chair8 Jul 2025now
Delegation to the Euro-Latin American Parliamentary AssemblyDLAT Parliamentary assemblyVice-chair30 Sept 2024now
Intergroup on Attracting Investment to Ensure a Competitive and Sustainable European UnionIG10-03 Intergroup / working groupMember31 Jan 2025now
Intergroup on Biodiversity, Hunting and CountrysideIG10-04 Intergroup / working groupMember4 Feb 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Cohesion Policy and Outermost RegionsIG10-08 Intergroup / working groupMember25 Feb 2025now

Show all 20 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Mission to Santa Cruz de Tenerife (Spain)Official delegationDLAT11 Sept 2026
Deliberations of the Committee on Petitions in 2025Shadow rapporteurPETI11 Sept 2026
No dossier namedOfficial delegationREGI10 Jul 2026
No dossier namedOfficial delegationSANT25 Jun 2026
EuroLat Parliamentary Assembly meetings in Mexico City (26-28 May 2026)Official delegationDLAT12 May 2026
EU rare disease action planShadow rapporteurSANT6 Mar 2026
EU rare disease action planShadow rapporteurSANT28 Jan 2026
Establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034Shadow rapporteur for an opinionTRAN28 Jan 2026
Establishing the European Social Fund as part of the National and Regional Partnership Plan set out in Regulation (EU) […] [NRPPlan] establishing conditions for the implementation of the Union support to quality employment, skills and social inclusion for the period from 2028 to 2034Shadow rapporteur for an opinionREGI16 Jan 2026
No dossier namedOfficial delegationREGI28 Jul 2025

Show all 20 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

38 contributions recorded; 2 on behalf of their group; 53 minutes of speaking time.

Show all 38 recent contributions

Questions and motions, 54

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
16 Sept 2026Gender gap in cardiovascular health and clinical research E-10-2026-003707Written questionNot yet answered
1 Jul 2026Procedure for banning monacolin K E-10-2026-002725Written questionwith 3 co-authorsNot yet answered
24 Jun 2026Continuity in mental health initiatives E-10-2026-002598Written question24 Aug 2026
15 Jun 2026MOTION FOR A RESOLUTION Political prisoners in Nicaragua – the cases of Carlos Brenes, Salvadora del Socorro Martínez Aburto and Brooklyn Rivera B-10-2026-0292Motion for a resolutionwith 26 co-authors—
12 Jun 2026MOTION FOR A RESOLUTION on the political repression and humanitarian situation in Cuba B-10-2026-0285Motion for a resolutionwith 6 co-authors—
9 Jun 2026Strengthening prevention, mental well-being and healthy ageing through improved hearing health E-10-2026-002380Written questionwith 15 co-authors21 Aug 2026
5 May 2026NextGenerationEU funds in Spain E-10-2026-001831Written questionwith 4 co-authors16 Sept 2026
5 May 2026NextGenerationEU funds in Spain E-10-2026-001830Written questionwith 4 co-authors27 Jul 2026
27 Mar 2026Ensuring that the fight against cancer remains a priority in the next multiannual financial framework (MFF) 2028-2034 E-10-2026-001292Written question4 Jun 2026
27 Mar 2026Strategic autonomy of the European Union and preparedness for health crises in the next multiannual financial framework E-10-2026-001291Written question15 Jun 2026
27 Mar 2026Cohesion funds diverted to defence priorities in Spain’s pluri-regional operational programme 2021-2027 E-10-2026-001290Written question11 May 2026
18 Mar 2026Investigation into irregular awarding of health equipment contracts with European funds during the COVID-19 pandemic in the Canary Islands E-10-2026-001107Written questionwith 1 co-author21 May 2026
18 Mar 2026Single register of leases and digital one-stop shop for rental accommodation E-10-2026-001106Written questionwith 1 co-author27 Apr 2026
13 Mar 2026Simplifying cross-border sales in the internal market E-10-2026-001058Written questionwith 21 co-authors26 May 2026
4 Mar 2026Judicial inquiries in Spain into alleged favourable treatment in the authorisation of renewable-energy projects E-10-2026-000902Written questionwith 2 co-authors12 Jun 2026
2 Mar 2026Possible breach of EU environmental legislation and use of the ERDF in a solar power project in a Natura 2000 network area in Spain E-10-2026-000855Written questionwith 1 co-author4 May 2026
2 Mar 2026Alleged favourable treatment of renewable energy projects in Spain during the term of office of current Commissioner Teresa Ribera E-10-2026-000857Written questionwith 1 co-authorNot yet answered
25 Feb 2026Delays with the feasibility study of the Ruta de la Plata rail corridor and its inclusion in the Trans-European Transport Network E-10-2026-000792Written questionwith 1 co-author28 Apr 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
3 Feb 2026Renfe’s announcement to stop paying compensation for high-speed train delays E-10-2026-000420Written questionwith 3 co-authors29 Apr 2026
29 Jan 2026Extraordinary regularisation of immigrants in Spain E-10-2026-000366Written questionwith 21 co-authors8 Apr 2026
9 Dec 2025MOTION FOR A RESOLUTION on the European citizens’ initiative entitled ‘My Voice, My Choice: For Safe and Accessible Abortion’ B-10-2025-0557Motion for a resolutionwith 35 co-authors—
28 Nov 2025Early diagnosis and treatment of uterine fibroids in Europe E-10-2025-004732Written question5 Feb 2026
28 Nov 2025Improvements in diagnosis and care for women with endometriosis in the European Union E-10-2025-004731Written question11 Feb 2026
24 Oct 2025Recognition of healthcare professions E-10-2025-004200Written questionwith 1 co-author5 Dec 2025
6 Oct 2025MOTION FOR A RESOLUTION on the arbitrary detention of EU citizens Javier Marañón Montero and David Rodríguez Ballesta in Equatorial Guinea B-10-2025-0441Motion for a resolutionwith 24 co-authors—
24 Sept 2025Continuity of the competence centre for tourism beyond 2026 E-10-2025-003719Written questionwith 1 co-author8 Dec 2025
22 Jul 2025Reassessing the timetable and safeguards for ETS2: preventing price shocks and ensuring social readiness E-10-2025-003032Written questionwith 48 co-authors12 Nov 2025
17 Jul 2025Study on the potential costs and impact of the Urban Wastewater Treatment Directive (UWWTD) on the pharmaceutical and cosmetic sectors. E-10-2025-002988Written questionwith 24 co-authors26 Sept 2025
2 Jul 2025MOTION FOR A RESOLUTION on the Commission delegated regulation of 10 June 2025 amending Delegated Regulation (EU) 2016/1675 to add Algeria, Angola, Côte d’Ivoire, Kenya, Laos, Lebanon, Monaco, Namibia, Nepal and Venezuela to the list of high-risk third countries which have provided a written high-level political commitment to address the identified deficiencies and have developed an action plan with the FATF, and to remove Barbados, Gibraltar, Jamaica, Panama, the Philippines, Senegal, Uganda and the United Arab Emirates from that list B-10-2025-0318Motion for a resolutionwith 48 co-authors—
1 Jul 2025Implementation of the UWWTD and pending analysis of the Extended Producer Responsibility scheme E-10-2025-002662Written questionwith 6 co-authors1 Sept 2025
27 Jun 2025Positioning cardiomyopathy in the cardiovascular health plan E-10-2025-002613Written questionwith 6 co-authors22 Aug 2025
22 May 2025Replacing the warning triangle with safer devices across the EU E-10-2025-002082Written question3 Jul 2025
7 May 2025Update of the EU Action Plan on Organ Donation and Transplantation E-10-2025-001838Written question30 Jul 2025
13 Mar 2025Impact of national restrictions on strategic autonomy and uranium supply in the EU E-10-2025-001097Written questionwith 21 co-authors10 Jun 2025
5 Mar 2025Modification of ERDF and ESF + Operational Programmes 2021-2027 following RESTORE E-10-2025-000921Written questionwith 1 co-author10 Apr 2025
26 Feb 2025Rare diseases P-10-2025-000845Priority written questionwith 7 co-authors2 May 2025
5 Feb 2025Repercussions of Royal Decree 933/2021 for the tourism sector – To the Commissioner for Prosperity and Industrial Strategy, Stéphane Séjourné E-10-2025-000519Written questionwith 1 co-author19 Mar 2025
27 Jan 2025Continued strengthening of the EU Solidarity Lanes to support Ukraine E-10-2025-000335Written questionwith 4 co-authors27 Mar 2025
24 Jan 2025Nuclear energy in the European Union E-10-2025-000320Written questionwith 21 co-authors16 Jun 2025
23 Jan 2025Potential security risks and geopolitical implications of the Iran-Venezuela alliance for the EU E-10-2025-000309Written questionwith 21 co-authors25 Mar 2025
22 Jan 2025Spanish Government’s strategy to decommission nuclear power plants E-10-2025-000267Written question18 Mar 2025
27 Nov 2024Paediatric transplants E-10-2024-002682Written question30 Jan 2025
8 Nov 2024DANA in Spain and the risk of medicine and vaccine shortages E-10-2024-002481Written question28 Jan 2025
8 Nov 2024Financial aid for rebuilding towns and cities in Spain affected by the recent torrential rainstorms E-10-2024-002480Written question15 Jan 2025
21 Oct 2024Labeling and designation of non-animal origin products E-10-2024-002194Written questionwith 20 co-authorsNot yet answered
17 Oct 2024Extraordinary measures to help the livestock sector to deal with bluetongue disease, bovine tuberculosis and epizootic haemorrhagic disease (EHD) E-10-2024-002156Written questionwith 2 co-authors6 Jan 2025
14 Oct 2024Transposition of Directive (EU) 2018/851 P-10-2024-002058Priority written questionwith 15 co-authors30 Nov 2024
11 Oct 2024Role of regional and local authorities in managing funds in the next programming period E-10-2024-002039Written questionwith 15 co-authors10 Jan 2025
3 Oct 2024Madrid-Lisbon high-speed rail link E-10-2024-001937Written questionwith 1 co-author22 Nov 2024

Amendments tabled in committee, 139

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
16 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792057 REGI17
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT4
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT12
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ643
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ645
7 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792058 REGI21
27 Aug 2026Cohesion policy in the EU’s eastern border regions: strengthening territorial resilience and cross-border cooperation REGI-AM-791869 REGI6
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT6

Show all 139 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Spain National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Elena NEVADO DEL CAMPO”. Member record. memberId 257039. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257039?docs=all&page=4&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257039. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257039?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257039,
  author = {{EU Parl Watch Research}},
  title = {{Elena NEVADO DEL CAMPO}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257039?docs=all&page=4&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/257039?docs=all&page=4&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257039. Official source: https://www.europarl.europa.eu/meps/en/257039. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}